Mini-Networking Night: Business Development in Healthcare & Life Sciences
Date/TimeDate - 20/11/2019
6:15 pm - 8:00 pm
LocationPrenup Pub, 191 College Street, Toronto,
Mini-Networking Night: Business Development in Healthcare & Life Sciences
Mini-Networking Night focused on careers in business development in healthcare and life sciences will feature guests from Ontario Bioscience Innovation Organization, Mitacs, Life Sciences Ontario, The Hospital for Sick Children, and the Centre for Commercialization of Regenerative Medicine on November 20th, 2019. Interested in learning more about this career path, join us for an exciting networking night where some of the most prominent leaders in the field in Toronto will talk about their path to success!
Date: Wednesday, November 20th, 2019
Registration: Opens on November 5th, 2019
Time: 6:15 – 8:00 pm
Location: Prenup Pub (191 College St., ), Second Floor.
Very limited space available. Registered individuals who do not show up will be prevented from registering for future events.
The Mini-Networking Series is $10 for all students, post-docs and other research trainees at the University of Toronto or the affiliated research institutions, to help cover the cost of food. External participants must pay a $15 fee to register.
Guests for this event:
Sean Peel, PhD – VP Strategic Programs – Ontario Bioscience Innovation Organization
Sarah Farr, PhD – Business Development Officer, Industry Partnerships & Commercialization – The Hospital for Sick Children
Wil de Vega, PhD – Business Development Specialist – Mitacs
Andrew Donovan, BA – Director, Member Engagement and Business Development – Life Sciences Ontario
Steven Molinski, PhD – Manager, Contract Services – Centre for Commercialization of Regenerative Medicine
Noah Schwartz, B.Eng, MBA – Licensing Professional – University Health Network
***Note: Ticket for U of T students and trainees are available for $10 to logged in users.***
Sean Peel, PhD
Sean leads OBIO’s Health to Business Bridge™ (H2BB) program. H2BB is a work-based learning program where recent graduates from undergraduate or graduate programs are placed in paid business and technical positions with health science companies. In parallel with their work placement, participants undergo skills assessment and training and are matched with a subject matter expert advisor. Sean also works with health science companies to help them raise investment required for product development and commercialization through OBIO’s Health MINT and CAAP programs. Sean has spent 23 years in the health science industry, building and leading teams in clinical product development for both start-up and established companies. Sean holds a Ph.D. in Oral Biology and completed a post-doctoral fellowship in tissue engineering.
Sarah Farr, PhD
Sarah facilitates the commercialization of SickKids’ leading-edge research and supports the advancement of these innovative, early-stage discoveries to the market. She works directly with researchers, physicians and scientists to transfer their knowledge into products and programs that have social and economic benefit. This involves identifying the steps required to protect, commercialize and license intellectual property and seek industry partners best-suited to drive the technology to market.
Sarah obtained her PhD from the University of Toronto in the Department of Laboratory Medicine & Pathobiology, where she studied the effects of an anti-diabetic therapy on risk factors for heart disease. She completed her Bachelor of Health Sciences with a minor in biochemistry from McMaster University.
Wil de Vega, PhD
Wil de Vega is a Business Development Specialist with Mitacs, a national non-profit organization that provides R&D funding to support academic-industry collaborations and international academic travel. He networks with various UofT academics and industry contacts to identify mutual research interests, and assists all applicants with navigating the various Mitacs funding opportunities to build long-term collaborations. Wil completed his PhD in 2017 in epigenomics at UTSC under the Biological Sciences and Cell & Systems Biology departments.
Andrew Donovan, BA
Andrew Donovan is a Certified Fund Raising Executive (CFRE) and current Director, Member Engagement and Business Development for Life Sciences Ontario. His success lies within his desire to build mutually beneficial relationships with members/donors in order for the investments for both to follow.
Prior to returning to the non-profit/charitable sector as a full-time employee, Andrew ran a successful consulting business specializing in fund development, communications and special events management. His company boasted a roster of national as well as internationally recognized charities where he played an integral role in helping to formulate both fundraising and communication strategies designed to inform, educate and engage their various audiences.
Andrew holds a Bachelor of Arts Degree from Carleton University in Political Science and Law as well as diplomas in Fundraising and Events Management from Algonquin College. Along with his volunteer roles at Endeavour as well as the Association of Fundraising Professionals (Toronto Chapter), he is also father to 11 year old triplets.
Steven Molinski, PhD
Steven received his PhD (Biochemistry, 2016) from U of T under the supervision of Christine Bear at SickKids, where he was involved with drug discovery efforts for rare Cystic Fibrosis mutations. During his PhD he also co-founded NeuroBlot, a startup company that developed a personalized memory test for individuals at-risk for dementia. Following his graduate studies, Steven joined Cyclica (Toronto-based drug discovery software company) as an Application Scientist, where he was responsible for business development, project design, client delivery, and internal research projects using Cyclica’s proprietary computational tools. Two years later he became Senior Solutions Scientist, Business Development, where he was responsible for global business development, contract drafting and negotiation, corporate strategy, and investor relations. Currently, Steven is the Contract Services Manager at the Centre for Commercialization of Regenerative Medicine (CCRM), responsible for business development activities relating to CCRM’s unique process development and cGMP manufacturing capabilities for global biotech/pharma companies developing cell and gene therapies. To date, Steven has co-authored 20+ peer-reviewed publications and three US provisional patent applications.
Noah Schwartz, B.Eng, MBA
Noah is responsible for technology development and commercialization at University Health Network’s Techna Institute. Noah focuses on the commercialization of medical devices and software, with a particular emphasis on artificial intelligence and devices for oncology, cardiology, and transplant medicine. He endeavors to sustainably maximize the impact of innovation through the marketing of new products and services that benefit the healthcare ecosystem. Prior to joining UHN, Noah has successfully developed and marketed novel health technologies for Diagand Antibodies, Aerotel Medical Systems, TCE Group and Policy Medical. Noah studied biology and mechanical engineering at the University of Toronto and holds an MBA from the Schulich School of Business with a specialization in Health Industry Management.